Deep Vein Thrombosis Research Today is a free monthly online journal that collates and summarizes the latest research about Deep Vein Thrombosis, including details on dvt, prevention, effects, causes, air travel, blood clots.

Volume 2 (2005), Issue 3 (March)

1. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
   Am J Hematol, 78(3): 167-72. [Abstract] [Full-text]
2. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
   Clin Chem, 51(3): 545-52. [Abstract] [Full-text]
3. Venous disorders: overview of current practice.
   J Vasc Nurs, 23(1): 33-5. [Abstract] [Full-text]
4. Outflow block secondary to stenosis of the inferior vena cava following living-donor liver transplantation?
   Clin Transplant, 19(2): 215-9. [Abstract] [Full-text]
5. Evolution of management for Budd-Chiari syndrome: a team's view from 2564 patients.
   ANZ J Surg, 75(1): 55-63. [Abstract] [Full-text]
6. Deep venous thrombosis and pulmonary embolism following physical restraint.
   Acta Psychiatr Scand, 111(4): 324-7; discussion 327. [Abstract] [Full-text]
7. Diagnosis accuracy of a new challenger for thrombosis exclusion, the Stratus CS DDMR.
   Clin Chim Acta, 354(1): 181-9. [Abstract] [Full-text]
8. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor.
   J Thromb Haemost, 3(3): 514-21. [Abstract] [Full-text]
9. Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists.
   J Thromb Haemost, 3(3): 473-81. [Abstract] [Full-text]
10. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).
    J Thromb Haemost, 3(3): 459-64. [Abstract] [Full-text]
11. Cerebral venous thrombosis in a patient with Evans syndrome: a rare association.
    Ann Hematol, 84(2): 124-6. [Abstract] [Full-text]
12. Ethnic differences in cerebral venous thrombosis.
    Cerebrovasc Dis, 19(3): 147-51. [Abstract] [Full-text]
13. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis.
    Br J Haematol, 128(6): 842-8. [Abstract] [Full-text]
14. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Int J Lepr Other Mycobact Dis, 72(4): 483-5. [Abstract] [Full-text]
15. Ultrasonographic assessment of the gallbladder in 21 children with portal vein thrombosis.
    Pediatr Radiol, 35(3): 290-4. [Abstract] [Full-text]
16. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
    N Engl J Med, 352(10): 969-77. [Abstract] [Full-text]
17. Catheter management of occluded superior baffle after atrial switch procedures for transposition of great vessels.
    Am J Cardiol, 95(6): 782-6. [Abstract] [Full-text]
18. Duplex ultrasound screening for deep vein thrombosis in Chinese after cesarean section.
    Acta Obstet Gynecol Scand, 84(4): 368-70. [Abstract] [Full-text]
19. Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae.
    Int J Biol Macromol, 35(1): 97-102. [Abstract] [Full-text]
20. Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid (CC-4047) and their relationship with venous thrombosis.
    Eur J Haematol, 74(4): 293-6. [Abstract] [Full-text]
21. The role of vena caval filters in the management of venous thromboembolism.
    Blood Rev, 19(4): 179-202. [Abstract] [Full-text]
22. Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels?
    J Interv Cardiol, 18(1): 21-5. [Abstract] [Full-text]
23. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement.
    J Intern Med, 257(4): 352-7. [Abstract] [Full-text]
24. Deep vein thrombosis.
    Lancet, 365(9465): 1163-74. [Abstract] [Full-text]
25. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
    Stroke, 36(4): 841-6. [Abstract] [Full-text]

© 2004-2008 Deep Vein Thrombosis Research Today. All Rights Reserved.